you. Let's turn to Starbucks this morning, as you might know, announcing plans to cut some corporate jobs, close some North American stores as part of the company's broader turnaround efforts. Let's get to Kate Rogers, who brought us that news earlier this morning.Morning again, Kate. Good morning, Carl. So, Starbucks announcing a $1 billion restructuring plan this morning in an SEC filing, adding that it will lay off some 900 non- retail employees and, as you said, closed stores.The number of company opera ...

Starbucks said Thursday it would shutter underperforming stores in North America and cut 900 jobs in a $1 billion restructuring effort, as CEO Brian Niccol presses ahead with his plan to revive the company’s fortunes.In his first year on the job, Niccol has zeroed in on investing in Starbucks’ stores to reduce service times and restore a coffee-house environment, while also trimming management layers.The company has posted six straight quarters of sales decline in the US as demand for its pricey lattes took ...

Company Performance - Novo Nordisk, the maker of Ozempic and Wegovy, is showing signs of a turnaround [1]

Core Insights - Madison Investments released its second-quarter 2025 investor letter for the Madison Small Cap Fund, highlighting a challenging start to the quarter due to catastrophic tariffs, followed by a rebound supported by positive macroeconomic data [1] - The Russell 2000 Index increased by 8.5% for the quarter, while the Madison Small Cap Fund (class Y) returned 4.42%, underperforming compared to the Russell 2000 and Russell 2500 [1] Company Analysis: The Hain Celestial Group, Inc. - The Hain Celestial Group, Inc. (NASDAQ:HAIN) has faced significant challenges, with a one-month return of -15.29% and a staggering 81.70% loss in value over the past 52 weeks, closing at $1.44 per share with a market capitalization of $130.022 million on September 17, 2025 [2] - The company has seen a notable decrease in food consumption, particularly in ultra-processed items, with reductions ranging from 6.7% to 11.1%, leading to disappointing Q1 results, especially in its salty snack brand [3] - Due to the difficulties in turnaround amidst shrinking volumes and frugal consumer behavior, the fund decided to exit its investment position in The Hain Celestial Group entirely, following a CEO replacement and ongoing strategic evaluations [3]

Group 1 - Jim Cramer discussed Under Armour, Inc. (NYSE:UA) in the context of potential earnings reporting changes and the impact on long-term business planning [2] - Cramer indicated that Under Armour's turnaround is not expected to happen in the current quarter, highlighting the focus on short-term performance by investors and analysts [2][3] - Cramer expressed support for Under Armour's CEO Kevin Plank but noted the intense competition in the industry from major players like Nike and New Balance, which poses challenges for the company [3] Group 2 - The article suggests that while Under Armour has potential, there are other investment opportunities, particularly in AI stocks, that may offer higher returns with lower risk [3]

Core Insights - V.F. Corporation (NYSE:VFC) is undergoing a turnaround effort and has recently announced the sale of its Dickies business for $600 million, which is seen as a significant move to improve its balance sheet [1][2]. Group 1: Company Overview - V.F. Corporation is an American apparel company currently focused on restructuring and improving its financial health [1]. - The sale of the Dickies brand is viewed as a strategic decision to enhance the company's balance sheet, which has been a concern [2]. Group 2: Market Reaction and Analyst Commentary - Jim Cramer highlighted V.F. Corporation as one of his favorite turnaround stories, emphasizing the importance of the Dickies sale in revitalizing the company's stock buyback efforts [2]. - The sale price of $600 million for Dickies suggests that the brand may hold more value than previously perceived, countering the notion that it was a tired brand [2].

Core Insights - Tapestry, Inc. (NYSE:TPR) is highlighted as a company undergoing a turnaround, particularly with its Kate Spade brand, focusing on simplifying its product lineup and appealing to younger consumers [2] - Jim Cramer emphasizes that Tapestry offers high-value products, which are characterized by quality at a reasonable price rather than low prices [2] - Cramer uses Tapestry as a model for other companies, suggesting that all firms need to undertake similar turnaround efforts [2] Company Overview - Tapestry, Inc. is a high-end American accessories, footwear, and jewelry company [2] - The company is known for its Coach brand, which has been discussed in the context of competitive strategies during challenging economic times [2] Market Commentary - Cramer expressed concerns regarding the impact of tariffs on Tapestry's stock performance, indicating that the company did not adequately signal the potential negative effects beforehand [3] - Despite acknowledging Tapestry's potential, there is a belief that certain AI stocks may offer greater returns with limited downside risk [3]

All right, four minutes before we get started with trading here for the uh first opening bell of the week. Let's get our first mad dash as well. VF Corp. Yeah, one of one of my favorites my favorite turnarounds and turnarounds are hard witnessed the negative note about Under Armour today is what Brack and Daryl's trying to engineer at VF Corp and he missed he didn't do it last quarter, the quarter being again a tough unit for for CEOs, but he's just sold Dickies which is a a a great brand.uh and for 600 B 6 ...

Company Overview - Kimberly-Clark Corporation (NASDAQ: KMB) is involved in manufacturing and marketing personal care and tissue products, including baby care, feminine care, adult incontinence, household paper goods, and professional hygiene solutions [2]. Core Insights - Jim Cramer highlighted Kimberly-Clark as a company undergoing a significant turnaround, emphasizing its restructuring efforts led by CEO Michael Hsu, despite the lack of recognition for these changes [1]. - The company has taken decisive action by selling 51% of its global Kleenex and tissue division to Brazilian supplier Suzano for $1.73 billion, allowing Kimberly-Clark to exit a cyclical business with low margins and focus on its more proprietary products, particularly in the diaper segment [2].

Claritev Corporation (NYSE:CTEV) FY Conference Summary Company Overview - **Company**: Claritev Corporation - **Industry**: Healthcare Technology - **Date of Conference**: September 09, 2025 Key Points and Arguments Company Journey and Strategic Priorities - The CEO, Travis Dalton, joined Claritev on March 1, 2023, viewing the company as having significant untapped potential in health tech [4][6] - The company underwent a turnaround focusing on clarity of purpose, alignment to attract talent, and focus on critical initiatives [5] - 2024 was framed as a foundational year, with successful restructuring of $4.5 billion in debt and positive momentum in business growth [6][7] Market Vertical Expansion - Claritev has repositioned around new market verticals, including partnerships like Brigio, which has opened international markets [8][10] - The company has renewed contracts with four of its five largest clients, indicating strong client retention and growth potential [8][9] - The Brigio partnership has led to a 3.5% improvement in claims processing, translating to $30 to $40 million in revenue for Brigio [11][12] End Market Dynamics - Payers are focused on managing risk and costs, while employers seek better benefits at lower costs [13][14] - Healthcare costs are rising significantly, with employer costs increasing by 78%, creating a favorable environment for Claritev's cost-reducing products [14][15] - The company is positioned to achieve single-digit growth due to its alignment with macroeconomic trends in healthcare [14][15] Provider Market Engagement - Claritev is expanding into the provider market with a product called Complete, which helps providers evaluate their pricing against competitors [17][18] - The company has signed seven clients in this vertical and is focused on helping employers optimize their health plans using AI [19][20] Recent Performance and Competitive Advantage - Claritev's success is attributed to hard work, trust, and a high Net Promoter Score (NPS) [21][22] - The company has implemented performance incentives and a broker incentive program to drive sales [23][24] - The focus on mastering the basics has led to improved sales performance and client engagement [25][26] Regulatory Landscape and Market Opportunities - The No Surprises Act is expected to remain, with providers winning most arbitration cases, presenting an opportunity for Claritev to offer outsourcing solutions [31][32] - The company anticipates continued growth in high-cost claims and has developed products for payment and revenue integrity, seeing double-digit growth in this area [33] Partnerships and Future Growth - Claritev has formed a commercial alliance with Echo to enhance healthcare payments, with over 30 deals in the pipeline [34][36] - The company is focused on deleveraging, diversifying, and accelerating growth, with a current leverage ratio of around eight times [46][47] - Future growth will focus on core markets, international expansion, and new product development [49][50] Innovation and AI Integration - Claritev is heavily investing in AI, with 37 models in production and plans to allocate a significant portion of capital expenditures to AI initiatives [42][43] - The company aims to innovate through strategic planning and product lifecycle management, enhancing its service offerings [40][41] Long-term Vision - The leadership emphasizes a relentless pursuit of growth and a shift towards a subscription-based business model [53][54] - Claritev aims to build foundational value and cash flow while cleaning up its capital structure to support future growth [54][55] Additional Important Insights - The company has quintupled the size of its product organization and completed its migration to Oracle Cloud, enhancing operational efficiency [27][28] - Claritev's focus on transparency and data availability aligns with market demands for better healthcare cost management [14][15] This summary encapsulates the key insights from the conference, highlighting Claritev Corporation's strategic direction, market engagement, and growth potential in the healthcare technology sector.